<DOC>
	<DOCNO>NCT02287298</DOCNO>
	<brief_summary>We propose undertake retrospective review approximately 200 patient diagnosis exudative macular degeneration treat triple combination therapy ( Bevacizumab , Dexamethasone Photo-dynamic therapy ) year 2006 2010 The Retina Center compare result additional group approximately 200 patient also treat triple combination therapy 20 mg daily oral zeaxanthin .</brief_summary>
	<brief_title>Triple Combination Therapy Choroidal Neovascularization AMD , Cost Effect Efficient Therapeutic Treatment</brief_title>
	<detailed_description>Study parameter include best correct visual acuity , number combination treatment , reduction central foveal thickness OCT measurement development exudative macular degeneration fellow eye . Follow include patient minimum two year . Retrospective review patient chart office The Retina Center .</detailed_description>
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Choroidal Neovascularization</mesh_term>
	<mesh_term>Neovascularization , Pathologic</mesh_term>
	<mesh_term>Wet Macular Degeneration</mesh_term>
	<criteria>MUST HAVE AGE RELATED MACULAR DEGENERATION</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>